======= ATF7IP ======= == Gene Information == * **Official Symbol**: ATF7IP * **Official Name**: activating transcription factor 7 interacting protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55729|55729]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6VMQ6|Q6VMQ6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ATF7IP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ATF7IP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613644|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A No Pfam Domain information is available for this gene. |positive regulation of methylation-dependent chromatin silencing| |regulation of methylation-dependent chromatin silencing| |regulation of RNA polymerase II transcriptional preinitiation complex assembly| |positive regulation of chromatin silencing| |regulation of transcription initiation from RNA polymerase II promoter| |regulation of DNA-templated transcription, initiation| |regulation of chromatin silencing| |DNA alkylation| |DNA methylation| |DNA methylation or demethylation| |DNA modification| |positive regulation of chromatin organization| |regulation of gene silencing| |positive regulation of chromosome organization| |protein stabilization| |regulation of chromatin organization| |transcription factor complex| |ATPase activity| |transcription corepressor activity| |macromolecule methylation| |nuclear body| |regulation of protein stability| |methylation| |regulation of chromosome organization| |regulation of protein complex assembly| |positive regulation of organelle organization| |viral process| |DNA metabolic process| |symbiotic process| |interspecies interaction between organisms| |negative regulation of transcription by RNA polymerase II| |regulation of cellular component biogenesis| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |regulation of organelle organization| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp287|HMS-I2 5μM R06 exp287]]|-2.49| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|-2.36| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-2.23| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.09| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|-2.02| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-2.01| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|-1.84| |[[:results:exp430|Rifampicin 30μM R08 exp430]]|-1.84| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-1.83| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.83| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|-1.83| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-1.81| |[[:results:exp432|YM155 0.001μM R08 exp432]]|-1.78| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|-1.72| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-1.7| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.72| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|1.74| |[[:results:exp17|DABN 20μM R00 exp17]]|1.74| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.79| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.05| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|2.22| |[[:results:exp443|SNS-032 15μM R08 exp443]]|2.26| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|2.38| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|2.67| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|2.83| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|2.85| |[[:results:exp59|UMK57 1μM R01 exp59]]|3.18| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|3.24| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|6.25| ^Gene^Correlation^ |[[:human genes:c:cbx3|CBX3]]|0.596| |[[:human genes:s:setdb1|SETDB1]]|0.538| |[[:human genes:m:mllt1|MLLT1]]|0.512| |[[:human genes:i:id3|ID3]]|0.51| |[[:human genes:t:thoc6|THOC6]]|0.506| |[[:human genes:m:med23|MED23]]|0.503| |[[:human genes:d:dhx29|DHX29]]|0.486| |[[:human genes:d:dohh|DOHH]]|0.47| |[[:human genes:c:ccdc101|CCDC101]]|0.468| |[[:human genes:g:gnb1l|GNB1L]]|0.463| |[[:human genes:m:mapk14|MAPK14]]|0.463| |[[:human genes:b:bap1|BAP1]]|0.459| |[[:human genes:n:nsd1|NSD1]]|0.457| |[[:human genes:z:znf592|ZNF592]]|0.451| |[[:human genes:m:maml1|MAML1]]|0.446| |[[:human genes:t:trip12|TRIP12]]|0.445| |[[:human genes:t:trim28|TRIM28]]|0.443| |[[:human genes:r:rptor|RPTOR]]|0.443| |[[:human genes:t:tti2|TTI2]]|0.442| |[[:human genes:c:cbfb|CBFB]]|0.435| |[[:human genes:a:arih1|ARIH1]]|0.433| |[[:human genes:t:taf5l|TAF5L]]|0.432| |[[:human genes:t:tada1|TADA1]]|0.425| |[[:human genes:a:arl14ep|ARL14EP]]|0.424| |[[:human genes:r:rnmt|RNMT]]|0.423| |[[:human genes:b:brpf1|BRPF1]]|0.421| |[[:human genes:d:ddx5|DDX5]]|0.419| |[[:human genes:a:aars|AARS]]|0.418| |[[:human genes:t:taf6l|TAF6L]]|0.417| |[[:human genes:s:ssbp2|SSBP2]]|0.417| |[[:human genes:t:tti1|TTI1]]|0.415| |[[:human genes:t:tmem41b|TMEM41B]]|0.415| |[[:human genes:h:hhex|HHEX]]|0.414| |[[:human genes:o:otud5|OTUD5]]|0.413| |[[:human genes:i:irf2bp2|IRF2BP2]]|0.413| |[[:human genes:f:fbxo11|FBXO11]]|0.412| |[[:human genes:g:gtf3c3|GTF3C3]]|0.412| |[[:human genes:l:lamtor4|LAMTOR4]]|0.411| |[[:human genes:t:tceb3|TCEB3]]|0.41| |[[:human genes:d:dpagt1|DPAGT1]]|0.409| |[[:human genes:d:dcaf5|DCAF5]]|0.406| |[[:human genes:x:xpot|XPOT]]|0.406| |[[:human genes:m:med16|MED16]]|0.405| |[[:human genes:z:znf445|ZNF445]]|0.402| |[[:human genes:s:sox7|SOX7]]|0.4| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6785 * **Expression level (log2 read counts)**: 6.92 {{:chemogenomics:nalm6 dist.png?nolink |}}